All Stories

  1. Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development

    Article • Scientific Reports, May 2016, Nature

    Dr Mounia Boulberdaa

  2. Prokineticin receptor 1 is required for mesenchymal-epithelial transition in kidney development

    Article • The FASEB Journal, April 2016, Federation of American Societies For Experimental Biology (FASEB)

    Dr. Canan G Nebigil, Dr Mounia Boulberdaa

  3. A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells

    Article • Molecular Therapy, February 2016, Nature

    Dr Mounia Boulberdaa

  4. Impaired vascular function and repair in patients with premature coronary artery disease

    Article • European Journal of Preventive Cardiology, August 2015, SAGE Publications

    Dr Mounia Boulberdaa

  5. 0369: Proepicardial prokineticin receptor –1 (PKR1) as a developmental link between heart and kidney

    Article • Archives of Cardiovascular Diseases Supplements, April 2014, Elsevier

    Dr Mounia Boulberdaa

  6. Prokineticin Receptor 1 as a Novel Suppressor of Preadipocyte Proliferation and Differentiation to Control Obesity

    Article • PLoS ONE, December 2013, PLOS

    Dr Mounia Boulberdaa

  7. Prokineticin Receptor-1 Is a New Regulator of Endothelial Insulin Uptake and Capillary Formation to Control Insulin Sensitivity and Cardiovascular and Kidney Functions

    Article • Journal of the American Heart Association, October 2013, Wolters Kluwer Health

    Dr Mounia Boulberdaa

  8. Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27

    Article • PLoS ONE, October 2011, PLOS

    Dr Mounia Boulberdaa

  9. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions

    Article • Cardiovascular Research, August 2011, European Society of Cardiology

    Dr Mounia Boulberdaa

  10. Genetic Inactivation of Prokineticin Receptor-1 Leads to Heart and Kidney Disorders

    Article • Arteriosclerosis Thrombosis and Vascular Biology, January 2011, Wolters Kluwer Health

    Dr Mounia Boulberdaa